Journal of Tropical Diseases & Public Health

Jaundice: Clinical Presentation, Underlying Causes, and Modern Management

Amira Solberg^* Department of Hepatology, Northern Plains University, Stockholm, Sweden
^*Correspondence: Amira Solberg, Department of Hepatology, Northern Plains University, Stockholm, Sweden, Email:

Received: 10-Nov-2025, Manuscript No. JTD-26-31179; Editor assigned: 12-Nov-2025, Pre QC No. JTD-26-31179 (PQ); Reviewed: 26-Nov-2025, QC No. JTD-26-31179; Revised: 03-Dec-2025, Manuscript No. JTD-26-31179 (R); Published: 10-Dec-2025, DOI: 10.35241/2329-891X.25.14.499

Description

Jaundice is a medical condition characterized by a yellow discoloration of the skin, sclerae of the eyes, and mucous membranes. This change in color results from an accumulation of bilirubin in the bloodstream, a pigment formed during the normal breakdown of red blood cells. Although jaundice itself is not a disease, it serves as a visible sign of underlying disturbances in liver function, bile flow, or red blood cell turnover. Identifying its cause is essential because the range of potential conditions varies from mild and temporary disorders to serious systemic illness.

Bilirubin metabolism follows a well-organized sequence within the body. When red blood cells reach the end of their lifespan, they are broken down in the spleen and other tissues. Hemoglobin, the oxygen-carrying component of these cells, is converted into unconjugated bilirubin. This form is transported to the liver, where it undergoes chemical modification to become conjugated bilirubin, making it water-soluble. The liver then excretes conjugated bilirubin into bile, which passes into the intestine and is eventually eliminated from the body. Disruption at any stage of this process may result in bilirubin accumulation and visible yellowing.

Types of jaundice are commonly categorized into three main types based on the origin of the problem: pre hepatic, hepatic, and post hepatic. Pre hepatic jaundice arises from excessive destruction of red blood cells, a condition known as hemolysis. When red blood cell breakdown occurs faster than the liver can process the resulting bilirubin, unconjugated bilirubin levels increase. Conditions such as certain inherited blood disorders, infections, or autoimmune reactions may trigger this process.

Hepatic jaundice results from liver cell dysfunction. In this form, the liver is unable to effectively process or excrete bilirubin. Viral hepatitis, alcohol-related liver disease, drug-induced liver injury, and chronic liver disorders such as cirrhosis can impair normal hepatic function. In such cases, both conjugated and unconjugated bilirubin levels may rise. Accompanying symptoms often include fatigue, abdominal discomfort, dark urine, and pale stools.

Post hepatic jaundice, also referred to as obstructive jaundice, occurs when bile flow from the liver to the intestine is blocked. Gallstones, tumors of the bile ducts or pancreas, and strictures within the biliary system may obstruct bile passage. When bile cannot drain properly, conjugated bilirubin accumulates in the bloodstream. Individuals with obstructive jaundice often notice intense itching, dark urine, and clay-colored stools due to the absence of bile pigments in the intestine.

Neonatal jaundice represents a special category frequently observed in newborns. In many cases, it is physiological and resolves without long-term consequences. Newborns produce higher levels of bilirubin because of increased red blood cell turnover, and their immature livers may not process bilirubin efficiently during the first days of life. However, excessive levels can pose risks, particularly to the developing brain. Monitoring and timely treatment, such as phototherapy, help reduce bilirubin concentrations and prevent complications.

Diagnosis of jaundice begins with clinical examination and laboratory testing. Blood tests measure total bilirubin levels and distinguish between conjugated and unconjugated forms. Liver enzyme tests provide insight into hepatic function, while complete blood counts may indicate hemolysis. Imaging studies, including ultrasound or computed tomography scans, can identify structural abnormalities or bile duct obstruction. In certain cases, further evaluation with specialized procedures may be required.

Management depends entirely on the underlying cause. For hemolytic conditions, treatment focuses on controlling red blood cell destruction. In cases of viral hepatitis, supportive care and antiviral therapy may be necessary. Alcohol-related liver injury requires abstinence and medical supervision. Obstructive causes often demand procedural intervention, such as endoscopic removal of gallstones or surgical correction of blockages. Addressing the primary disorder typically leads to resolution of jaundice.

Conclusion

Jaundice is a visible sign of elevated bilirubin levels resulting from disruptions in red blood cell breakdown, liver processing, or bile excretion. Its causes range from benign newborn conditions to significant liver or biliary disease. Accurate diagnosis, guided by clinical evaluation and laboratory testing, is essential for effective management. Through early detection and appropriate intervention, many underlying causes can be treated successfully, restoring normal bilirubin levels and overall health. Research into liver disease continues to expand understanding of bilirubin metabolism and hepatic repair mechanisms. Advances in antiviral therapy, minimally invasive surgical techniques, and liver transplantation have improved outcomes for many patients with severe liver disorders.